UC San Diego Health Ranks #1 Regionally by U.S. News & World Report
UC San Diego Health top ranked in 10 medical and surgical specialties, among the nation’s best.
The Latest
A Novel COVID-19 Vaccine Using Modified Bacterial DNA
UC San Diego researchers describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods.
Post-COVID Lung Disease Shares Origins with Other Scarring Lung Disorders
UC San Diego researchers provide first insights into the fundamental cellular pathologies that drive interstitial lung disease in patients post-COVID.
Novel Treatment Approach to Alzheimer’s Disease Uses Vitamin B1 Derivative
With a $45 million grant from the NIH, UC San Diego researchers and collaborators will launch a nationwide clinical trial to further investigate the therapeutic potential of benfotiamine, a synthetic version of thiamine (B1), as a treatment for Alzheimer’s disease.
Global Supply Chains Remain Resilient in the Wake of Natural Disasters
While many U.S. policy makers are calling for reshoring and nearshoring to combat trade disruptions caused by COVID-19, new University of California San Diego School of Global Policy and Strategy research suggests retrenchment of global supply chains is unlikely to happen.
Did Gonorrhea Give Us Grandparents?
UC San Diego researchers tracked the evolution of a gene variant that supports cognitive health in older humans, but may have first emerged to protect against bacteria.
Stay in the Know
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
